Vertical fate of Cd in soil under phytoremediation by Indian mustard and tall fescue.

Soil columns were designed to investigate the vertical migration of Cd in Indian mustard (IM) and tall fescue (TF). The TF biomass was greater than the IM biomass, and the Cd content in IM was higher in the shoots but lower in the roots than that in TF. Both IM and TF released N and absorbed P and K during outdoor growth, differing from the results of the previous experiment in which plants were grown in greenhouses. TF was more absorbent and had less upward attraction than IM. The IM soil was more favorable for Cd precipitation than was the TF soil. Leaching remained the dominant effect, with only 2.28-3.40% and 2.65-3.90% of Cd absorbed by IM and TF, respectively. The present study on the vertical migration of Cd provides new insights into the phytoremediation mechanisms of IM and TF. HIGHLIGHTSVertical migration rate of Cd in soil was calculated.Cd precipitation in IM soil was greater and more excellence than TF soil.TF was more absorbent and had less upward attraction than IM.Leaching remained the dominant effect with only small absorb.

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.

The 2015 European pulmonary hypertension (PH) guidelines propose a risk stratification strategy for patients with pulmonary arterial hypertension (PAH). Low-, intermediate- and high-risk strata are defined by estimated 1-year mortality risks of <5%, 5-10% and >10%, respectively. This risk assessment strategy awaits validation.We analysed data from patients with newly diagnosed PAH enrolled into COMPERA (Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension), a European-based PH registry. An abbreviated version of the risk assessment strategy proposed by the European PH guidelines was applied, using the following variables: World Health Organization functional class, 6-min walking distance, brain natriuretic peptide or its N-terminal fragment, right atrial pressure, cardiac index and mixed venous oxygen saturation.Data from 1588 patients were analysed. Mortality rates were significantly different between the three risk strata (p<0.001 for all comparisons). In the entire patient population, the observed mortality rates 1 year after diagnosis were 2.8% in the low-risk cohort (n=196), 9.9% in the intermediate-risk cohort (n=1116) and 21.2% in the high-risk cohort (n=276). In addition, the risk assessment strategy proved valid at follow-up and in major PAH subgroups.An abbreviated version of the risk assessment strategy proposed by the current European PH guidelines provides accurate mortality estimates in patients with PAH.

First identification of Krüppel-like factor 2 mutation in heritable pulmonary arterial hypertension.

Heritable pulmonary arterial hypertension (HPAH) is an autosomal dominantly inherited disease caused by mutations in the bone morphogenic protein receptor 2 (BMPR2) gene and/or genes of its signalling pathway in approximately 85% of patients. We clinically and genetically analysed an HPAH family without mutations in previously described pulmonary arterial hypertension (PAH) genes. Clinical assessment included electrocardiogram, lung function, blood gas analysis, chest X-ray, laboratory testing, echocardiography and right heart catheterization in case of suspected disease. Genetic diagnostics were performed using a PAH-specific gene panel including all known 12 PAH genes and 20 further candidate genes by next-generation sequencing (NGS). HPAH was invasively confirmed in two sisters and their father who died aged 32 years. No signs of HPAH were detected in five first-degree family members. Both sisters were lung transplanted and remained stable during a follow-up of >20 years. We detected a novel missense mutation in the Krüppel-like factor 2 (KLF2) likely leading to a disruption of gene function. The same KLF2 mutation has been described as a recurrent somatic mutation in B-cell lymphoma. Neither the healthy family members carried the mutation nor >120000 controls. These findings point to KLF2 as a new PAH gene. Further studies are needed to assess frequency and implication of KLF2 mutations in PAH patients.

Partial Unbalanced Feature Transport for Cross-Modality Cardiac Image Segmentation.

Deep learning based approaches have achieved great success on the automatic cardiac image segmentation task. However, the achieved segmentation performance remains limited due to the significant difference across image domains, which is referred to as domain shift. Unsupervised domain adaptation (UDA), as a promising method to mitigate this effect, trains a model to reduce the domain discrepancy between the source (with labels) and the target (without labels) domains in a common latent feature space. In this work, we propose a novel framework, named Partial Unbalanced Feature Transport (PUFT), for cross-modality cardiac image segmentation. Our model facilities UDA leveraging two Continuous Normalizing Flow-based Variational Auto-Encoders (CNF-VAE) and a Partial Unbalanced Optimal Transport (PUOT) strategy. Instead of directly using VAE for UDA in previous works where the latent features from both domains are approximated by a parameterized variational form, we introduce continuous normalizing flows (CNF) into the extended VAE to estimate the probabilistic posterior and alleviate the inference bias. To remove the remaining domain shift, PUOT exploits the label information in the source domain to constrain the OT plan and extracts structural information of both domains, which are often neglected in classical OT for UDA. We evaluate our proposed model on two cardiac datasets and an abdominal dataset. The experimental results demonstrate that PUFT achieves superior performance compared with state-of-the-art segmentation methods for most structural segmentation.

DeU-Net 2.0: Enhanced deformable U-Net for 3D cardiac cine MRI segmentation.

Automatic segmentation of cardiac magnetic resonance imaging (MRI) facilitates efficient and accurate volume measurement in clinical applications. However, due to anisotropic resolution, ambiguous borders and complicated shapes, existing methods suffer from the degradation of accuracy and robustness in cardiac MRI segmentation. In this paper, we propose an enhanced Deformable U-Net (DeU-Net) for 3D cardiac cine MRI segmentation, composed of three modules, namely Temporal Deformable Aggregation Module (TDAM), Enhanced Deformable Attention Network (EDAN), and Probabilistic Noise Correction Module (PNCM). TDAM first takes consecutive cardiac MR slices (including a target slice and its neighboring reference slices) as input, and extracts spatio-temporal information by an offset prediction network to generate fused features of the target slice. Then the fused features are also fed into EDAN that exploits several flexible deformable convolutional layers and generates clear borders of every segmentation map. A Multi-Scale Attention Module (MSAM) in EDAN is proposed to capture long range dependencies between features of different scales. Meanwhile, PNCM treats the fused features as a distribution to quantify uncertainty. Experimental results show that our DeU-Net achieves the state-of-the-art performance in terms of the commonly used evaluation metrics on the Extended ACDC dataset and competitive performance on other two datasets, validating the robustness and generalization of DeU-Net.

Efficient removal of Cr(VI) at alkaline pHs by sulfite/iodide/UV: Mechanism and modeling.

Efficient removal of toxic hexavalent chromium (Cr(VI)) under alkaline conditions is still a challenge due to the relatively low reactivity of CrO42-. This study proposed a new sulfite/iodide/UV process to remove Cr(VI). The removal of Cr(VI) followed pseudo-zero-order kinetics at alkaline pHs, and was enhanced by sulfite and iodide with synergy. Compared with sulfite/UV, iodide in sulfite/iodide/UV showed about 40 times higher concentration-normalized enhancement for Cr(VI) removal, and reduced the requirement of sulfite ([S(IV)]0/[Cr(VI)]0 of about 2.1:1) by more than 90%. The Cr(VI) removal was accelerated by decreasing pH and by increasing temperature, and was slightly influenced by dissolved oxygen, carbonate, and humic acid. The process was still effective in real surface water and industrial wastewater. Mechanism and pathways of Cr(VI) removal were revealed by quenching experiments, competition kinetic analysis, product identification and quantification, and mass and electron balance. Both eaq- and SO3•- were responsible for Cr(VI) removal, making contributions of about 75% and 25%, respectively. When eaq- mainly reacted with Cr(VI), SO3•- participated in reduction of Cr(V) and Cr(IV) intermediates, with Cr(III), S2O62-, and SO42- as the final products. A model was developed to predict removal kinetics of Cr(VI), and well interpreted the roles of S(IV) and iodide in the process. This study sheds light on mechanism of Cr(VI) removal at alkaline pHs by kinetic modeling, and thus advances the applicability of this promising process for water decontamination.

Genetically predicted insomnia and lung cancer risk: a Mendelian randomization study.

BACKGROUND: The relationship between insomnia and lung cancer is scanty. The Mendelian randomization approach provides the rationale for evaluating the potential causality between genetically-predicted insomnia and lung cancer risk. METHODS: We extracted 148 insomnia-related single-nucleotide polymorphisms (SNPs) as instrumental variables (IVs) from published genome-wide association studies (GWASs). Summary data of individual-level genetic information of participants were obtained from the International Lung Cancer Consortium (ILCCO) (29,266 cases and 56,450 controls). MR analyses were performed using the inverse-variance-weighted approach, MR pleiotropy residual sum and outlier (MR-PRESSO) test, weighted median estimator, and MR-Egger regression. Sensitivity analyses were further performed using Egger intercept analysis, leave-one-out analysis, MR-PRESSO global test, and Cochran's Q test to verify the robustness of our findings. RESULTS: The results of the MR analysis indicated an increased risk of lung cancer in insomnia patients (OR = 1.1671; 95% CI 1.0754-1.2666, p = 0.0002). The subgroup analyses showed increased risks of lung adenocarcinoma (OR = 1.1878; 95% CI 1.0594-1.3317, p = 0.0032) and squamous cell lung cancer (OR = 1.1595; 95% CI 1.0248-1.3119, p = 0.0188). CONCLUSION: Our study indicated that insomnia is a causal risk factor in the development of lung cancer. Due to the lack of evidence on both the epidemiology and the mechanism level, more studies are needed to better elucidate the results of the study.

MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway.

PURPOSE: MicroRNA-936 (miR-936) was previously reported to be dysregulated and involved in the development of non-small cell lung cancer and glioma. However, the functional roles of miR-936 in epithelial ovarian cancer (EOC) remain unclear. In this study, we aimed to evaluate miR-936 expression in EOC and investigate its regulatory role in EOC cell behavior. METHODS: The expression of miR-936 in EOC was measured by RT-qPCR. Cell proliferation, apoptosis, migration, and invasion in vitro, as well as tumor growth in vivo, were determined by CCK-8, flow cytometry, migration and invasion assays, and xenograft models in nude mice, respectively. Bioinformatics analysis, luciferase reporter assays, RT-qPCR, and Western blot analysis were performed to investigate the relationship between miR-936 and fibroblast growth factor 2 (FGF2). RESULTS: miR-936 expression was significantly downregulated in EOC tissues and cell lines. Low miR-936 expression was found to be correlated with the tumor size, FIGO stage, and lymphatic metastasis in EOC patients. Functional experiments indicated that ectopic miR-936 expression suppressed EOC cell proliferation, migration, and invasion; promoted cell apoptosis; and decreased tumor growth in vivo. In addition, the FGF2 gene was verified to be a direct target of miR-936 in EOC cells. FGF2 expression levels were upregulated in EOC tissues and were inversely correlated with miR-936 expression. Furthermore, effects of FGF2 silencing were similar to those of miR-936 overexpression in EOC cells. Recovered FGF2 expression rescued the miR-936-induced inhibitory effects in EOC cells. Notably, miR-936 was able to deactivate the PI3K/Akt signaling pathway in EOC cells by regulating FGF2 both in vitro and in vivo. CONCLUSION: Altogether, our findings provided initial evidence that miR-936 inhibits the aggressiveness of EOC cells in vitro and in vivo, at least partially, by targeting FGF2-mediated suppression of the PI3K/Akt pathway. Therefore, the miR-936/FGF2/PI3K/Akt pathway is a promising therapeutic target for the treatment of EOC patients.

Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study).

OBJECTIVE: The objective of this randomized, placebo-controlled, double-blind, parallel group, trial was to assess the effect of ambrisentan on mean pulmonary arterial pressure (mPAP) in patients with systemic sclerosis (SSc) and mildly elevated pulmonary hypertension (PH). METHODS: Thirty-eight SSc patients with mildly elevated mPAP at rest between 21 and 24 mmHg and/or > 30 mmHg during low-dose exercise were randomly assigned to treatment with either ambrisentan 5-10 mg/day or placebo. Right heart catheterization and further clinical parameters were assessed at baseline and after 6 months. The primary endpoint was the difference of mPAP change at rest between groups. RESULTS: After 6 months, the two groups did not differ in the primary endpoint (ambrisentan mPAP - 1 ± 6.4 mmHg vs. placebo - 0.73 ± 3.59 mmHg at rest, p = 0.884). However, three patients from the placebo group but none of the ambrisentan group progressed to SSc-associated pulmonary arterial hypertension. Furthermore, ambrisentan treatment showed significant improvements in the secondary endpoints cardiac index (CI) and pulmonary vascular resistance (PVR) at rest (CI 0.36 ± 0.66 l/min/m2 vs. - 0.31 ± 0.71 l/min/m2, p = 0.010; PVR - 0.70 ± 0.78 WU vs. 0.01 ± 0.71 WU, p = 0.012) and during exercise (CI 0.7 ± 0.81 l/min/m2 vs. - 0.45 ± 1.36 l/min/m2, p = 0.015; PVR - 0.84 ± 0.48 WU vs. - 0.0032 ± 0.34 WU, p < 0.0001). CONCLUSION: This is the first randomized, double-blind, placebo-controlled study testing the effect of ambrisentan in patients with mildly elevated mPAP and/or exercise PH. The primary endpoint change in mPAP did only tendentially improve in the ambrisentan group, but the significant improvement of other hemodynamic parameters points to a possible benefit of ambrisentan and will be helpful to design future trials. TRIAL REGISTRATION: www.ClinicalTrials.gov, unique identifier NCT: NCT02290613 , registered 14th of November 2014.

Directional sensing based on flexible aligned carbon nanotube film nanocomposites.

The electrical behaviors under mechanical deformation of an aligned single-walled carbon nanotube (SWCNT) film nanocomposite have been systematically investigated in this work. Electrical signals along the CNT axis (‖) and perpendicular to the CNT axis (⊥) follow a specific pattern, which enables the mechanical motion to be determined by vector analysis of such signals. The unique electrical behaviors of the sandwiched nanocomposites originate from the anisotropic characteristics of the CNT films. By combining in situ mechanical investigation with a coarse-grained molecular dynamics simulation, the shearing effect between SWCNTs is found to play a key role in stress-transfer along the ‖ direction, resulting in arc-shape cracks, while the peeling effect is dominant along the ⊥ direction, leading to unifom SWCNT bar bridging at cracks. The fabricated CNT based sandwiched nanocomposite is believed to have great potential in building flexible all-direction sensors.

Establishment of a novel method for primary culture of normal human cervical keratinocytes.

BACKGROUND: Cervical keratinocytes are recovered at a low numbers and frequently associated with contaminating human fibroblasts which rapidly overgrow the epithelial cells in culture with medium supplemented with 10% fetal bovine serum (FBS). However, it is difficult to initiate keratinocyte cultures with serum-free keratinocyte growth medium alone because cell attachment can be poor. Therefore, the culture of these cells is extremely difficult. In this study, we described a modified culture medium and coated culture plastics for growing normal human cervical epithelial cells in vitro. METHODS: Normal cervical epithelial tissue pieces were obtained and digested with type I collagenase to dissociate the cells and a single cell suspension produced. The cells were cultured on plastic tissue culture substrate alone or substrate coated with collagen type I from rat tail, with modified keratinocyte serum-free medium (K-SFM) supplemented with 5% FBS. After attachment, the medium were replaced with K-SFM without FBS. The expression of basal keratins of the ectocervical epithelium, K5, K14 and K19 were assayed by immunofluorescence with monoclonal antibodies to identify the cell purity. RESULTS: Our results indicate that cells attached to the culture plastic more quickly in K-SFM supplemented with 5% FBS than in K-SFM alone, as well as to tissue culture plastic coated with collagen type I than plastic alone. The modified medium composed of K-SFM and 5% FBS combined with a specific tissue culture plastic coated with collagen type I from rat tail was the best method for culture of normal cervical epithelial cells. K5, K14 and K19 were assayed and keratinocyte purity was nearly 100%. CONCLUSION: A novel, simple and effective method can be used to rapidly obtain highly purified keratinocytes from normal human cervical epithelium.